España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Comments
Close menu
Loading...
Adaptimmune Therapeutics
ADAP
NASDAQ
Watchlist
Leave a Comment
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$1.39
0.09
6.92%
At Close: -
$1.42
0.03
2.16%
After Hours: 7:35 PM EDT
15 minutes delayed
Get Report
Comment
Adaptimmune Therapeutics (ADAP) Forecast
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Adaptimmune Therapeutics (NASDAQ:ADAP) Stock
Adaptimmune Therapeutics Stock (NASDAQ: ADAP)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Monday, June 17, 2024
ADAP: Initiating Coverage of Adaptimmune, a Leading T-Cell Therapy Company
Zacks Small Cap Research
Friday, May 31, 2024
Why SentinelOne Shares Are Trading Lower By 16%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Avi Kapoor
Why Adaptimmune Therapeutics (ADAP) Stock Is Moving
Henry Khederian
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga Insights
Adaptimmune Therapeutics shares are trading h...
Benzinga Newsdesk
Why Zscaler Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
Thursday, May 30, 2024
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga Insights
Adaptimmune Therapeutics shares are trading h...
Benzinga Newsdesk
Galapagos And Adaptimmune Enter Clinical Coll...
Benzinga Newsdesk
Scotiabank Initiates Coverage On Adaptimmune ...
Benzinga Newsdesk
Friday, May 17, 2024
Mizuho Maintains Buy on Adaptimmune Therapeut...
Benzinga Newsdesk
Wednesday, May 15, 2024
Adaptimmune Therapeutics Q1 2024 GAAP EPS $(0...
Benzinga Newsdesk
Friday, April 19, 2024
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga Insights
Friday, April 12, 2024
Adaptimmune Therapeutics shares are trading l...
Benzinga Newsdesk
Adaptimmune Therapeutics Says On April 10, Un...
Benzinga Newsdesk
Friday, March 08, 2024
Why Marvell Technology Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Avi Kapoor
Smith & Wesson Brands Reports Upbeat Earnings, Joins America's Car-Mart, HCI Group And Other Big Stocks Moving Higher On Friday
Avi Kapoor
Wednesday, March 06, 2024
Adaptimmune Therapeutics shares are trading h...
Benzinga Newsdesk
Adaptimmune Says Cash Runway Into Early 2026,...
Benzinga Newsdesk
Adaptimmune Therapeutics Q4 EPS $(0.04) Beats...
Benzinga Newsdesk
Earnings Scheduled For March 6, 2024
Benzinga Insights
Tuesday, March 05, 2024
Adaptimmune Therapeutics Earnings Preview
Benzinga Insights
Tuesday, February 06, 2024
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights
Wednesday, January 31, 2024
Adaptimmune Announces US FDA Acceptance Of Bi...
Benzinga Newsdesk
Monday, January 29, 2024
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga Insights
Friday, December 15, 2023
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga Insights
Wednesday, December 06, 2023
Adaptimmune Therapeutics Says It Completed Su...
Benzinga Newsdesk
Wednesday, November 08, 2023
Adaptimmune Therapeutics Q3 EPS $(0.18) Misse...
Benzinga Newsdesk
Earnings Scheduled For November 8, 2023
Benzinga Insights
Tuesday, October 31, 2023
Adaptimmune Reports Better Outcomes For Peopl...
Benzinga Newsdesk
Tuesday, September 19, 2023
Stocks That Hit 52-Week Lows On Tuesday
Benzinga Insights
Friday, September 08, 2023
Stocks That Hit 52-Week Lows On Friday
Benzinga Insights
Thursday, September 07, 2023
Stocks That Hit 52-Week Lows On Thursday
Benzinga Insights
Friday, August 25, 2023
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga Insights
Thursday, August 24, 2023
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga Insights
Thursday, August 10, 2023
Stocks That Hit 52-Week Lows On Thursday
Benzinga Insights
Analyst Expectations for Adaptimmune Therapeutics's Future
Benzinga Insights
Barclays Maintains Underweight on Adaptimmune...
Benzinga Newsdesk
EF Hutton Reiterates Buy on Adaptimmune Thera...
Benzinga Newsdesk
Monday, August 07, 2023
Stocks That Hit 52-Week Lows On Monday
Benzinga Insights
Friday, July 28, 2023
Stocks That Hit 52-Week Lows On Friday
Benzinga Insights
Tuesday, June 06, 2023
Stocks That Hit 52-Week Lows On Tuesday
Benzinga Insights
Monday, June 05, 2023
EF Hutton Reiterates Buy on Adaptimmune Thera...
Benzinga Newsdesk
Friday, May 26, 2023
EF Hutton Reiterates Buy on Adaptimmune Thera...
Benzinga Newsdesk
Friday, May 12, 2023
Earnings Scheduled For May 12, 2023
Benzinga Insights
Recap: Adaptimmune Therapeutics Q1 Earnings
Benzinga Insights
Adaptimmune Therapeutics Q1 EPS $0.00 Up From...
Benzinga Newsdesk
Thursday, May 11, 2023
Earnings Preview For Adaptimmune Therapeutics
Benzinga Insights
Monday, April 17, 2023
EF Hutton Reiterates Buy on Adaptimmune Thera...
Benzinga Newsdesk
Tuesday, April 11, 2023
EF Hutton Reiterates Buy on Adaptimmune Thera...
Benzinga Newsdesk
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch